FDA
Femasys Secures FDA Approval and $12M Financing for FemBloc Trial
100% left coverage1 source
FDA
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA
Femasys Secures FDA Approval and $12M Financing for FemBloc Trial
100% left coverage1 source
FDA
FDA Lifts Full Clinical Hold on Rein Therapeutics Phase 2 IPF Trial
100% left coverage1 source
FDA
FDA Lifts Full Clinical Hold on Rein Therapeutics Phase 2 IPF Trial
100% left coverage1 source
FDA
uniQure Faces FDA Approval Uncertainty for Huntington’s Gene Therapy Amid Data Concerns
50% center coverage2 sources
FDA
uniQure Faces FDA Approval Uncertainty for Huntington’s Gene Therapy Amid Data Concerns
50% center coverage2 sources
FDA
TScan Therapeutics Plans 30% Workforce Cut, FDA Agrees Pivotal Study Design
100% left coverage1 source
FDA
TScan Therapeutics Plans 30% Workforce Cut, FDA Agrees Pivotal Study Design
100% left coverage1 source
FDA
Benitec Biopharma Reports Promising BB-301 Phase 1b/2a Trial Results for OPMD
100% left coverage1 source
FDA
Benitec Biopharma Reports Promising BB-301 Phase 1b/2a Trial Results for OPMD
100% left coverage1 source
FDA
Alvotech Revises 2025 Outlook After FDA CRL on AVT05 Biosimilar
100% left coverage1 source
FDA
Alvotech Revises 2025 Outlook After FDA CRL on AVT05 Biosimilar
100% left coverage1 source
FDA
Alvotech Shares Plunge 22% After FDA CRL for AVT05 Biosimilar Application
100% left coverage1 source
FDA
Alvotech Shares Plunge 22% After FDA CRL for AVT05 Biosimilar Application
100% left coverage1 source
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA